Treatment intensification in patients with inadequate glycemic control on basal insulin: rationale and clinical evidence for the use of short-acting and other glucagon-like peptide-1 receptor agonists
about
P2860
Treatment intensification in patients with inadequate glycemic control on basal insulin: rationale and clinical evidence for the use of short-acting and other glucagon-like peptide-1 receptor agonists
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Treatment intensification in p ...... ke peptide-1 receptor agonists
@ast
Treatment intensification in p ...... ke peptide-1 receptor agonists
@en
Treatment intensification in p ...... ke peptide-1 receptor agonists
@nl
type
label
Treatment intensification in p ...... ke peptide-1 receptor agonists
@ast
Treatment intensification in p ...... ke peptide-1 receptor agonists
@en
Treatment intensification in p ...... ke peptide-1 receptor agonists
@nl
prefLabel
Treatment intensification in p ...... ke peptide-1 receptor agonists
@ast
Treatment intensification in p ...... ke peptide-1 receptor agonists
@en
Treatment intensification in p ...... ke peptide-1 receptor agonists
@nl
P2093
P2860
P921
P356
P1476
Treatment intensification in p ...... ke peptide-1 receptor agonists
@en
P2093
Francesco Giorgino
Paolo Pozzilli
Sandro Gentile
P2860
P304
P356
10.1002/DMRR.2775
P407
P5008
P577
2016-09-01T00:00:00Z